Página principal > Resultados de la búsqueda: Cephalalgia
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Depósito Digital de Documentos de la UAB Encontrados 7 registros  La búsqueda tardó 0.00 segundos. 
1.
12 p, 986.0 KB Perceived barriers to career progression in the headache field : A global web-based cross-sectional survey / de Boer, Irene (Leiden University Medical Center) ; Ambrosini, Anna (IRCCS Neuromed (Itàlia)) ; Halker Singh, Rashmi B (Mayo Clinic (Estats Units d'Amèrica)) ; Baykan, Betül (Istanbul University) ; Buse, Dawn C (DepAlbert Einstein College of Medicine) ; Tassorelli, Cristina (University of Pavia) ; Jensen, Rigmor H (University of Copenhagen) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Terwindt, Gisela M (Leiden University Medical Center) ; Universitat Autònoma de Barcelona
It is well recognized that underrepresented and minoritized groups do not have the same career opportunities. However, there are limited data on the range and specifics of potential barriers that withhold people in headache medicine and science from reaching their full potential. [...]
2022 - 10.1177/03331024221123081
Cephalalgia, Vol. 42 (september 2022) , p. 1498-1509  
Registro completo - Creative Commons
2.
10 p, 705.8 KB Migraine-attributed burden, impact and disability, and migraine-impacted quality of life : Expert consensus on definitions from a Delphi process / Steiner, Timothy J (Imperial College London) ; Terwindt, Gisela M (Leiden University Medical Center) ; Katsarava, Zaza (EVEX Medical Corporation (Georgia)) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gantenbein, Andreas R (University Hospital Zurich (Suïssa)) ; Roche, Sarah L (Eli Lilly and Company) ; Dell'Agnello, Grazia (Eli Lilly Italia SpA) ; Tassorelli, Cristina (IRCCS Mondino Foundation) ; Universitat Autònoma de Barcelona
Migraine-attributed burden, impact, disability and migraine-impacted quality of life are important concepts in clinical management, clinical and epidemiological research, and health policy, requiring clear and agreed definitions. [...]
2022 - 10.1177/03331024221110102
Cephalalgia, Vol. 42 (july 2022) , p. 1387-1396  
Registro completo - Creative Commons
3.
14 p, 552.6 KB Fremanezumab for the Preventive Treatment of Migraine : Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response / Pazdera, Ladislav (Vestra Clinics (República Txeca)) ; Cohen, Joshua M. (Teva Branded Pharmaceutical Products (Estats Units d'Amèrica)) ; Ning, Xiaoping (Teva Branded Pharmaceutical Products (Estats Units d'Amèrica)) ; Campos, Verena Ramirez (Teva Branded Pharmaceutical Products (Estats Units d'Amèrica)) ; Yang, Ronghua (Teva Branded Pharmaceutical Products (Estats Units d'Amèrica)) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
To evaluate the efficacy of monthly or quarterly fremanezumab in patients with chronic migraine or episodic migraine and documented inadequate response to 2, 3, or 4 classes of prior migraine preventive medications. [...]
2021 - 10.1177/03331024211008401
Cephalalgia, Vol. 41 (may 2021) , p. 1075-1088  
Registro completo - Creative Commons
4.
12 p, 641.2 KB Headache : A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution / Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ballvé, Alejandro (Hospital Universitari Vall d'Hebron) ; Llaurado, Arnau (Hospital Universitari Vall d'Hebron) ; Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ariton, Diana María (Hospital Universitari Vall d'Hebron) ; Lallana, Sofia (Hospital Universitari Vall d'Hebron) ; López Maza, Samuel (Hospital Universitari Vall d'Hebron) ; Olivé-Gadea, Marta (Hospital Universitari Vall d'Hebron) ; Quibus, Laura (Hospital Universitari Vall d'Hebron) ; Restrepo, Juan Luis (Hospital Universitari Vall d'Hebron) ; Rodrigo-Gisbert, Marc (Hospital Universitari Vall d'Hebron) ; Vilaseca, Andreu (Hospital Universitari Vall d'Hebron) ; Hernandez Gonzalez, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez Gallo, Monica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pujol Borrell, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Álvarez Sabín, José (Hospital Universitari Vall d'Hebron) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona. Departament de Medicina
To define headache characteristics and evolution in relation to COVID-19 and its inflammatory response. This is a prospective study, comparing clinical data and inflammatory biomarkers of COVID-19 patients with and without headache, recruited at the Emergency Room. [...]
2020 - 10.1177/0333102420965157
Cephalalgia, Vol. 40 (november 2020) , p. 1410-1421  
Registro completo - Creative Commons
5.
15 p, 678.4 KB Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache Society / Diener, Hans-Christoph (Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany) ; Ashina, Messoud (University of Copenhagen) ; Durand-Zaleski, Isabelle (Santé Publique Hôpital Henri Mondor, Créteil, France) ; Kurth, Tobias (Charité - Universitätsmedizin Berlin) ; Lantéri-Minet, Michel (Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France) ; Lipton, Richard B. (Albert Einstein College of Medicine) ; Ollendorf, Daniel A. (Value Measurement and Global Health Initiatives, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, , Boston, MA, USA) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tassorelli, Cristina (Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy) ; Terwindt, Gisela (Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands) ; Universitat Autònoma de Barcelona
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. [...]
2021 - 10.1177/0333102421989247
Cephalalgia, Vol. 41 (january 2021) , p. 279-293  
Registro completo - Creative Commons
6.
13 p, 823.6 KB Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine : The multicentre, double-blind, randomised, sham-controlled PREMIUM trial / Diener, Hans-Christoph (University Duisburg-Essen) ; Goadsby, Peter J. (King's College London) ; Ashina, Messoud (Glostrup University Hospital Copenhagen) ; Al-Karagholi, Mohammad Al-Mahdi (Glostrup University Hospital Copenhagen) ; Sinclair, Alexandra J. (Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham) ; Mitsikostas, Dimos (1st National and Kapodistrian University of Athens) ; Magis, Delphine (CHR East Belgium) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Irimia Sieira, Pablo (Clínica Universidad de Navarra) ; Làinez, Miguel J. A. (Universidad Católica de Valencia) ; Gaul, Charly (Migraine and Headache Clinic) ; Silver, Nicholas (The Walton Centre) ; Hoffmann, Jan (King's College London) ; Marin, Juana (King's College London) ; Liebler, Eric (electroCore, Inc., Basking Ridge) ; Ferrari, Michel D.. (Leiden University Medical Center) ; Universitat Autònoma de Barcelona
Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential to prevent migraine days in patients with migraine on the basis of mechanistic rationale and pilot clinical data. This multicentre study included a 4-week run-in period, a 12-week double-blind period of randomised treatment with nVNS or sham, and a 24-week open-label period of nVNS. [...]
2019 - 10.1177/0333102419876920
Cephalalgia, Vol. 39 (september 2019) , p. 1475-1487  
Registro completo - Creative Commons
7.
24 p, 365.1 KB Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth edition / Diener, Hans-Christoph (University Hospital Essen (Alemanya)) ; Tassorelli, Cristina (University of Pavia) ; Dodick, David W. (Mayo Clinic) ; Silberstein, Stephen D. (Thomas Jefferson University) ; Lipton, Richard B. (Albert Einstein College of Medicine) ; Ashina, Messoud (University of Copenhagen) ; Becker, Werner J. (University of Calgary) ; Ferrari, Michel D.. (Leiden University Medical Center) ; Goadsby, Peter J. (King's College London) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ; Wang, Shuu-Jiun (National Yang-Ming University) ; Mandrekar, Jay (Mayo Clinic Rochester) ; Universitat Autònoma de Barcelona
The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. [...]
2019 - 10.1177/0333102419828967
Cephalalgia, Vol. 39 (february 2019) , p. 687-710  
Registro completo - Creative Commons

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos